Terrance Mcguire

Insider Reports History

Entity
Individual
Location
C/O Polaris Venture Partners Lp, 1000 Winter Street, Suite 3350, Waltham, MA
Signature
/s/ Lauren Crockett, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Terrance Mcguire:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Alector, Inc. Director, 10%+ Owner Common Stock 10.9M $60.3M $5.56 Sep 11, 2023 Indirect
Invivyd, Inc. Director Common Stock 3.69M $1.6M $0.43 Dec 19, 2024 Indirect
Alector, Inc. Director, 10%+ Owner Common Stock 55K $306K $5.56 Sep 11, 2023 Direct
Seer, Inc. Director Class A Common Stock 91.6K $186K $2.03 Jun 12, 2024 Direct
Seer, Inc. Director Class A Common Stock 78.9K $160K $2.03 Jun 12, 2024 Indirect
Cyclerion Therapeutics, Inc. Director Common Stock 34.9K $118K $3.40 Nov 30, 2023 By Polaris Partners VIII, L.P
Tectonic Therapeutic, Inc. Director Common Stock 64.7K $84K $1.30 Jun 20, 2024 Indirect
Cyclerion Therapeutics, Inc. Director Common Stock 5.55K $18.8K $3.40 Nov 30, 2023 Direct
Cyclerion Therapeutics, Inc. Director Common Stock 1.25K $4.23K $3.40 Nov 30, 2023 By Polaris Entrepreneurs 'Fund VIII, L.P.
Cyclerion Therapeutics, Inc. Director Common Stock 345 $1.17K $3.40 Nov 30, 2023 By Bartlett Partners, LLC
Invivyd, Inc. Director Stock Option (Right to Buy) 50K May 21, 2024 Direct
Seer, Inc. Director Stock Option (right to buy) 34.7K Jun 14, 2023 Direct
Tectonic Therapeutic, Inc. Director Stock Option (Right to Buy) 11.8K Jun 20, 2024 Direct

Insider Reports Filed by Terrance Mcguire

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IVVD Invivyd, Inc. Dec 17, 2024 3 -$148K 4 Dec 19, 2024 Director
IVVD Invivyd, Inc. Dec 12, 2024 2 -$103K 4 Dec 16, 2024 Director
IVVD Invivyd, Inc. Dec 9, 2024 3 -$289K 4 Dec 11, 2024 Director
TECX Tectonic Therapeutic, Inc. Jun 20, 2024 4 $0 4 Jun 24, 2024 Director
TECX Tectonic Therapeutic, Inc. Jun 20, 2024 0 $0 3 Jun 24, 2024 Director
SEER Seer, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
IVVD Invivyd, Inc. May 29, 2024 1 -$187K 4 May 31, 2024 Director
IVVD Invivyd, Inc. May 21, 2024 1 $0 4 May 23, 2024 Director
CYCN Cyclerion Therapeutics, Inc. Nov 30, 2023 1 $0 4 Dec 4, 2023 Director
ALEC Alector, Inc. Sep 11, 2023 1 -$3M 4 Sep 13, 2023 Director, 10%+ Owner
ALEC Alector, Inc. Aug 22, 2023 5 $0 4 Aug 24, 2023 Director, 10%+ Owner
CYCN Cyclerion Therapeutics, Inc. Aug 9, 2023 1 -$27 4 Aug 11, 2023 Director
SEER Seer, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
ALEC Alector, Inc. Jun 14, 2023 2 $0 4 Jun 15, 2023 Director, 10%+ Owner
IVVD Invivyd, Inc. May 23, 2023 1 $0 4 May 25, 2023 Director
ALEC Alector, Inc. Nov 16, 2022 5 $0 4 Nov 18, 2022 Director, 10%+ Owner
IVVD Adagio Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
ALEC Alector, Inc. Jun 16, 2022 2 $0 4 Jun 21, 2022 Director
SEER Seer, Inc. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
CYCN Cyclerion Therapeutics, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
IVVD Adagio Therapeutics, Inc. Mar 28, 2022 0 $0 4 Mar 30, 2022 Director, Other*
ALEC Alector, Inc. Dec 21, 2021 5 $0 4 Dec 23, 2021 Director, 10%+ Owner
IVVD Adagio Therapeutics, Inc. Aug 10, 2021 28 $8.5M 4 Aug 12, 2021 Director
IVVD Adagio Therapeutics, Inc. Aug 5, 2021 1 $0 4 Aug 9, 2021 Director
IVVD Adagio Therapeutics, Inc. Aug 5, 2021 0 $0 3 Aug 5, 2021 Director
CYCN Cyclerion Therapeutics, Inc. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director
SEER Seer, Inc. Jun 17, 2021 1 $0 4 Jun 22, 2021 Director
ALEC Alector, Inc. Jun 17, 2021 1 $0 4 Jun 22, 2021 Director
CYCN Cyclerion Therapeutics, Inc. Jun 3, 2021 2 $300K 4 Jun 7, 2021 Director